Significantly, while our findings and existing literature establish USP37 as a promoter of tumorigenesis and metastasis in cancers like LIHC (Zhang S. et al., 2025), its association with favorable prognosis in KIRC presents a compelling tissue-specific paradox. Here, USP37 is linked to cancer.